8 compounds · from $40.50
Glowmaxxing — GHK-Cu, GLOW Blend, KLOW Blend & Melanotan
Glowmaxxing is the shelf where the compounds are judged on what shows up in a mirror rather than on a scale. GHK-Cu anchors it: a copper-binding tripeptide with a dermatology research record stretching back to the 1970s, and one of the few peptides with a published gene-expression signature broad enough to be interesting on its own terms. SNAP-8 works a completely different mechanism — partial SNARE complex inhibition, which attenuates the repetitive micro-contractions that etch expression lines in over years. Melanotan I and Melanotan II are α-MSH analogues that drive melanogenesis without UV exposure, with MT-II adding MC4R activity as a secondary effect. The GLOW and KLOW blends exist for people who would rather run one vial than stack three, and both are listed below alongside the individual compounds.
GHK-Cu 50mg
$45.00
GHK-Cu 100mg
$80.99
GLOW Blend 50mg
$80.99
GLOW Blend 70mg
$98.99
KLOW Blend 80mg
$107.99
Melanotan I 10mg
$53.99
Melanotan II 10mg
$53.99
SNAP-8 10mg
$40.50
What the GHK-Cu Gene Data Actually Says
The number that gets quoted about GHK-Cu is 4,000-plus genes, from a 2012 Broad Institute expression analysis, and the direction of those changes is the part worth reading. Collagen I rose roughly 70% in fibroblast models and collagen III around 50%, alongside elastin, glycosaminoglycans and the antioxidant enzymes superoxide dismutase and catalase. Moving the other way were inflammatory mediators, senescence markers and the matrix metalloproteinases that degrade structural protein. Building structure while suppressing what dismantles it is an unusual combination, and it is the reason GHK-Cu is treated as the base layer rather than a specialty addition. Plasma levels drop roughly 60% between age twenty and sixty, which is the argument for supplementing it at all.
SNAP-8 Is Not a Botox Equivalent
Both act on the SNARE complex, but the resemblance stops at the mechanism family. Botulinum toxin cleaves SNARE proteins outright, producing complete neuromuscular blockade at the injection site. SNAP-8 is an eight-residue extension of the SNAP-25 N-terminus that competes for complex assembly — it reduces contraction intensity rather than eliminating it. Preclinical in vitro work put wrinkle depth reduction at up to 63%, which is meaningful but is a different order of effect from full blockade. The practical difference is that SNAP-8 is dose-titratable and topical, and it stacks with GHK-Cu because the two address entirely separate causes of visible aging.
Melanotan I vs Melanotan II
Melanotan I is the more selective of the pair, binding MC1R with relatively little activity elsewhere, which makes its effect profile narrow — melanogenesis, essentially. Melanotan II is promiscuous across the melanocortin receptor family, and the MC4R activity in particular produces appetite suppression and, in a substantial fraction of users, spontaneous erection as a well-documented off-target effect. Neither compound removes the need for care around existing nevi, and both are typically run as a short loading phase followed by maintenance rather than continuously.